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Gellular transport
N
uclear pores are plugged with a protein gel, say 
Steffen Frey, Ralf Richter, and Dirk Görlich (Universität 
Heidelberg, Germany). The researchers succeeded in 
forming the gel in vitro and believe that in vivo it forms a hydro-
phobic mesh—a mesh that can be breached only by small 
proteins or by the hydrophobic nuclear transport receptors 
(NTRs) that escort larger proteins in and out of the nucleus.
The group focused on the Phe and Gly (FG)-rich repeats 
present in many nuclear pore proteins. The effective concentration 
of the repeat proteins in the pore is close to 100 mg/ml. “At such 
a concentration, a gel must form,” says Görlich.
But proving that in vitro was not easy. Agarose makes a gel, 
but only if the powder is ﬁ  rst boiled with water to make a homoge-
neous solution. A similar approach does not work with FG repeats, 
whose hydrophobic interactions are largely unresponsive to heat. 
Finally, the German group found that a regime of pH changes 
could give a similar result: a hydrogel whose properties are com-
parable to those of a 0.4% agarose gel. Gel formation runs coun-
ter to some other models for nuclear pore action, which only work 
if repeat proteins do not signiﬁ  cantly interact with each other.
Repeat proteins with Phe residues mutated to Ser could no 
longer form the in vitro gels, bind to NTRs, or rescue nucleoporin 
mutants. Phe-to-Tyr mutants also failed to bind NTRs but could 
still rescue nucleoporin mutants. Apparently, the Tyr version in-
teracted with the mesh enough to fulﬁ  ll the essential function—
maintenance of a barrier—and other nucleoporins helped out 
by interacting with NTRs.
The next step, says Görlich, will be to demonstrate that the 
in vitro gel can act as a selective permeability barrier. How 
might such a solid-looking structure perform this function? One 
might think the multivalent interaction between gel and NTR 
would freeze any movement, but “it’s analogous to water,” says 
Görlich. “A protein diffuses through water even though it has 
bonds with water. It’s just a matter of how fast the rearrange-
ments occur.” The NTRs, he says, must use their hydrophobicity 
to catalyze the necessary exchange.
Reference: Frey, S., et al. 2006. Science. 314:815–817.
Fever brings in the lymphocytes
“I
n whatever part of the body there is a sweat, it shows that the disease is seated 
there,” said Hippocrates. Now, Qing Chen, Sharon Evans (Roswell Park 
Cancer Institute, Buffalo, NY), and colleagues fi  nd that fever turns on homing 
molecules that direct lymphocytes into lymph nodes. The increased traffi  cking through 
lymph nodes should increase the chance of a lymphocyte encountering and being 
activated by its target antigen-presenting cell.
Higher temperatures are known to be benefi  cial for postinfection survival. Cold-blooded 
animals do better if they can seek out the sun when infected. Infected warm-blooded 
animals incur a 15% increase in metabolic cost for every 1°C rise in core temperature, 
suggesting that the benefi  t may be equally high.
The most obvious response to fever is that vasodilation (an attempt to cool down the 
body) increases blood fl  ow, thus increasing the sheer number of cells that pass by high en-
dothelial venules (HEVs), the entry gates to lymph nodes. “If anybody thinks of fever at all, 
they think of it in those terms,” says Evans. “But we think there is an additional change besides the physics.”
Evans turned up the temperature to 39.5°C, and then returned it to normal before the experiment began so 
that blood fl  ow effects were eliminated. Her team found that the initial rolling interaction of lymphocytes on 
HEVs was unchanged, but two key downstream molecules were up-regulated. The CCL21 chemokine and 
ICAM-1 adhesion molecule (both on HEVs) mediate a post-rolling arrest that is required for entry through 
HEVs, and lumenal presentation of both was increased up to twofold by the prior increase in temperature.
IL-6 signaling is required for the heat-induced up-regulation of the traffi  cking and ICAM-1 but not of 
CCL21. It is not yet clear what turns on IL-6 or what makes the signaling so specifi  c to HEVs.
The fever signal might be particularly useful when there is a rare antigen or when a previously localized 
infection spreads. So should we all suffer through our fevers rather than combat them with drugs? “I’m the 
biggest hypocrite,” says Evans. “If I don’t feel well I take a Tylenol.” She says the study has important clinical 
implications, but for most people “if we take a Tylenol it’s not going to be the deciding factor.”
Reference: Chen, Q., et al. 2006. Nat. Immunol. doi:10.1038/ni1406.
Heat (bottom)-induced increases in ICAM-1 and 
















Repeats from nucleoporins can form a gel (left) unless mutated (right).
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